Insider Transactions Reported by 21 Insiders of NOVAVAX INC

Symbol
NVAX on Nasdaq
Location
Gaithersburg, MD

There are no Buy or Sell transactions made by insiders since 06 Mar 2025

NOVAVAX INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John C. Jacobs President and CEO, Director $17,498,597 03 Mar 2026
Elaine O'Hara EVP, Chief Strategy Officer $6,988,028 03 Mar 2026
James Patrick Kelly EVP, CFO and Treasurer $5,589,519 03 Mar 2026
Mark J. Casey EVP, Chief Legal Officer $4,523,375 03 Mar 2026
Ruxandra Draghia-Akli EVP, Research & Development $2,416,663 02 Mar 2026
Filip Dubovsky President, R&D $1,226,227 17 Jun 2024
John Trizzino President and COO $808,572 07 Mar 2025
JAMES F. YOUNG Director $806,810 24 Dec 2024
DAVID M. MOTT Director $703,599 20 Jun 2025
DOUGLAS RICHARD Director $663,054 20 Jun 2025
John W. Shiver Director $521,114 10 Mar 2025
Gregg H. Alton Director $504,992 20 Jun 2025
MARGARET G. MCGLYNN Director $485,079 20 Jun 2025
Rachel K. King Director $482,616 20 Jun 2025
Richard J. Rodgers Director $459,260 29 Oct 2025
Stanley C. Erck President and CEO, Director $195,098 14 Dec 2022
Gregory M. Glenn President, R&D $149,795 06 Mar 2023
Gary C. Evans Director $83,279 17 Jun 2021
John A. Herrmann III EVP, Chief Legal Officer $56,373 14 Dec 2023
Michael McManus Director $43,030 16 Jun 2022
Charles W. Newton Director 25 Apr 2025

Recent Insider Transactions by Companies or Individuals for NOVAVAX INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.